Daimonrecta 20 mg 4 tablets

Trade name:

Diamonrecta

Diamonrecta

Composition

Each tablet contains:

Tadalafil 20 mg

Auxiliary components:

Lactose monohydrate, croscarmellose sodium, hydroxypropyl cellulose, microcrystalline cellulose, magnesium stearate.

Properties

Tadalafil is a reversible selective inhibitor of specific phosphodiesterase type 5 (PDE5) of cyclic guanosine monophosphate (cGMP). When sexual arousal causes a local release of nitric oxide, inhibition of PDE5 by tadalafil leads to an increase in the concentration of cGMP in the corpus cavernosum of the penis. The consequence of this is relaxation of the smooth muscles of the arteries and blood flow to the tissues of the penis, which causes an erection. Tadalafil has no effect in the absence of sexual arousal.

Indications

-erectile disfunction;

— symptoms of the lower urinary tract in patients with benign prostatic hyperplasia (for a dosage of 5 mg);

— erectile dysfunction in patients with lower urinary tract symptoms on the background of benign prostatic hyperplasia (for a dosage of 5 mg).

Contraindications

-use of preparations containing any organic nitrates;

-the presence of contraindications to sexual activity in patients with diseases of the cardiovascular system.

— loss of vision due to non-arterial anterior ischemic neuropathy of the optic nerve (regardless of the connection with the use of PDE5 inhibitors);

Side effects

From the nervous system: often — headache; infrequently — dizziness.

From the side of the vessels: often — «hot flushes» of blood to the face; infrequently — a decrease in blood pressure, an increase in blood pressure.

From the respiratory system: often — nasal congestion.